Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaAnne-Marie Daull, Vincent Alcazer, Marie‐Virginie Larcher et al.|Frontiers in Immunology|2022Cited by 25
Thrombocytosis drives alteration of primary hemostasis and acquired von willebrand syndrome occurrence in myeloproliferative neoplasmsGabriel Antherieu, Maël Heiblig, Hamdi Rezigue et al.|Blood|2025Cited by 1
A baseline transcriptomic signature predictive of clinical response to menin inhibitors in AML : The PRE-men retrosprospective StudyVincent Alcazer, Maël Heiblig, Sandrine Hayette et al.|Blood|2025Cited by 0